Samsara BioCapital, LLC - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,677,000
+210.4%
881,450
-53.6%
1.32%
+171.3%
Q2 2022$1,829,000
-19.1%
1,899,6160.0%0.49%
-14.2%
Q1 2022$2,261,000
-63.8%
1,899,616
-13.2%
0.57%
-53.0%
Q4 2021$6,243,000
-27.6%
2,189,1990.0%1.21%
-10.5%
Q3 2021$8,624,000
-18.6%
2,189,1990.0%1.35%
+3.4%
Q2 2021$10,599,000
-28.2%
2,189,1990.0%1.31%
-52.0%
Q1 2021$14,769,000
-32.4%
2,189,1990.0%2.72%
+24.0%
Q4 2020$21,837,000
+88.1%
2,189,199
+55.5%
2.20%
-32.2%
Q3 2020$11,608,000
-26.8%
1,407,949
-10.4%
3.24%
-36.6%
Q2 2020$15,866,000
+65.3%
1,571,903
-9.0%
5.10%
-7.6%
Q1 2020$9,599,000
-14.7%
1,726,6030.0%5.52%
+2.4%
Q4 2019$11,255,000
-33.8%
1,726,6030.0%5.39%
-53.4%
Q3 2019$17,012,000
+11.7%
1,726,6030.0%11.58%
+15.1%
Q2 2019$15,228,000
+57.2%
1,726,603
+62.9%
10.06%
+32.1%
Q1 2019$9,688,000
+64.1%
1,059,9380.0%7.61%
+34.4%
Q4 2018$5,904,0001,059,9385.67%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders